Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review

被引:50
|
作者
Guo, Jingbo [1 ]
Shao, Jie [1 ]
Yang, Yuan [2 ]
Niu, Xiaodan [1 ]
Liao, Juan [1 ]
Zhao, Qing [1 ]
Wang, Donghui [1 ]
Li, Shuaitong [1 ]
Hu, Junping [1 ,2 ]
机构
[1] Lanzhou Univ, Sch Nursing, Lanzhou, Peoples R China
[2] Lanzhou Univ, Reprod Med Special Hosp, Key Lab Reprod Med & Embryo, Hosp 1, Lanzhou, Peoples R China
关键词
Microbiota; Polycystic ovary syndrome; Comparison; Dysbiosis; Systematic review; INSULIN-RESISTANCE; SYNDROME PCOS; WOMEN; INFLAMMATION; OBESITY; HEALTH; EXPRESSION; PARAMETERS; DYSBIOSIS; WEIGHT;
D O I
10.1007/s43032-020-00430-0
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Polycystic ovary Syndrome (PCOS) is one of the most popular diseases that cause menstrual dysfunction and infertility in women. Recently, the relationships between the gastrointestinal microbiome and metabolic disorders such as obesity, type 2 diabetes and PCOS have been discovered. However, the association between the gut microbiome and PCOS symptoms has not been well established. We systematically reviewed existing studies comparing gut microbial composition in PCOS and healthy volunteers to explore evidence for this association. A systematic search was carried out in PubMed, Embase, Cochrane Library, and Web of Science from inception to May 26, 2020, for all original cross-sectional, cohort, or case-control studies comparing the fecal microbiomes of patients with PCOS with microbiomes of healthy volunteers (controls). The primary outcomes were differences in specific gut microbes between patients with PCOS and controls. The search identified 256 citations; 10 studies were included. The total population study of these articles consists of 611 participants (including PCOS group and healthy controls group). Among the included 10 studies, nine studies compared alpha-diversity, and six studies demonstrated that alpha-diversity has a significant reduction in PCOS patients. Seven of them reported that there was a significant difference of beta-diversity composition between healthy controls groups and PCOS patients. The most common bacterial alterations in PCOS patients included Bacteroidaceae, Coprococcus, Bacteroides, Prevotella, Lactobacillus, Parabacteroides, Escherichia/Shigella, and Faecalibacterium prausnitzii. No consensus has emerged from existing human studies of PCOS and gut microbiome concerning which bacterial taxa are most relevant to it. In this systematic review, we identified specific bacteria associated with microbiomes of patients with PCOS vs controls. Higher level of evidence is needed to determine whether these microbes are a product or cause of PCOS.
引用
收藏
页码:69 / 83
页数:15
相关论文
共 50 条
  • [21] Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review
    He, Fang-fang
    Li, Yu-mei
    JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
  • [22] Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome
    Liu, Rui
    Zhang, Chenhong
    Shi, Yu
    Zhang, Feng
    Li, Linxia
    Wang, Xuejiao
    Ling, Yunxia
    Fu, Huaqing
    Dong, Weiping
    Shen, Jian
    Reeves, Andrew
    Greenberg, Andrew S.
    Zhao, Liping
    Peng, Yongde
    Ding, Xiaoying
    FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [23] Role of polyphenols in remodeling the host gut microbiota in polycystic ovary syndrome
    Ping Zhou
    Penghui Feng
    Baoying Liao
    Lin Fu
    Hongying Shan
    Canhui Cao
    Renxin Luo
    Tianliu Peng
    Fenting Liu
    Rong Li
    Journal of Ovarian Research, 17
  • [24] Association of Gut Microbiota With Fatigue in Black Women With Polycystic Ovary Syndrome
    Slack, Julia E.
    Kosyakova, Natalia
    Pelkmans, Jordan L.
    Houser, Madelyn C.
    Dunbar, Sandra B.
    Spencer, Jessica B.
    Ferranti, Erin P.
    Narapareddy, S. Laren
    NURSING RESEARCH, 2025, 74 (01) : 56 - 63
  • [25] Curcumin and Polycystic Ovary Syndrome: a Systematic Review
    Shojaei-Zarghani, Sara
    Molani-Gol, Roghayeh
    Rafraf, Maryam
    REPRODUCTIVE SCIENCES, 2022, 29 (08) : 2105 - 2118
  • [26] Role of polyphenols in remodeling the host gut microbiota in polycystic ovary syndrome
    Zhou, Ping
    Feng, Penghui
    Liao, Baoying
    Fu, Lin
    Shan, Hongying
    Cao, Canhui
    Luo, Renxin
    Peng, Tianliu
    Liu, Fenting
    Li, Rong
    JOURNAL OF OVARIAN RESEARCH, 2024, 17 (01)
  • [27] Curcumin and Polycystic Ovary Syndrome: a Systematic Review
    Sara Shojaei-Zarghani
    Roghayeh Molani-Gol
    Maryam Rafraf
    Reproductive Sciences, 2022, 29 : 2105 - 2118
  • [28] Potential roles of carnitine in patients with polycystic ovary syndrome: a systematic review
    Maleki, Vahid
    Jafari-Vayghan, Hamed
    Kashani, Arvin
    Moradi, Fardin
    Vajdi, Mahdi
    Kheirouri, Sorayya
    Alizadeh, Mohammad
    GYNECOLOGICAL ENDOCRINOLOGY, 2019, 35 (06) : 463 - 469
  • [29] Alteration in gut mycobiota of patients with polycystic ovary syndrome
    Chen, Ke
    Geng, Huafeng
    Liu, Junbao
    Ye, Cong
    MICROBIOLOGY SPECTRUM, 2023, 11 (05):
  • [30] Alteration in gut mycobiota of patients with polycystic ovary syndrome
    Chen, Ke
    Geng, Huafeng
    Liu, Junbao
    Ye, Cong
    MICROBIOLOGY SPECTRUM, 2023,